Method: ALK1 and BMP-9 expression were investigated by immunohistochemistry in tumors and adjacent normal follicles of 78 PTCs with bone formation and 64 PTCs without bone formation. ALK1 and BMP-9 expression were further verified by quantitative real time polymerase chain reaction in each group of 15 cases of PTCs with or without bone formation.